Susan Dexter
Chief Technical Officer at Sonnet Biotherapeutics Β· Executive at Sonnet BioTherapeutics Holdings
Rye, New Hampshire, United States
Find your path to Susan
243 people in our graph share verified history with Susan β schools, employers, funds. One of them is your warm intro.
Linda AveyunlockedSusan: together at American University (1981β1983)
Γ11Susan: together at American University
Chief Technical Officer at Sonnet Biotherapeutics
Co-founders at Sonnet Biotherapeutics
PM
Pankaj MohanChief Executive Officer
Executive at Sonnet BioTherapeutics Holdings
Co-founders at Sonnet BioTherapeutics Holdings
PM
Pankaj MohanExecutive Officer, Director
Experience
- Guidant BioTherapeuticsChief Technology Officercurrent2026 β presentPrinceton Innovation Center-BioLabs, Princeton, NJ
- Sonnet BioTherapeutics, Inc.Chief Technical Officercurrent2020 β presentPrinceton, New Jersey, United States
- Sonnet BioTherapeutics, Inc.Chief Technical Officer2020Princeton, New Jersey, United States
- Latham BioPharm GroupPrincipal Consultant2007 β 2020
- Latham BioPharm GroupManaging Director, Commercial Business2007 β 2020Rye, NH
- BioPharm Services, IncPrincipal Consultant2007 β 2010
- XcellerexChief Business Officer2004 β 2007
- Dow ChemicalVP, Business Development, Dow Biopharmaceutical Contract Manufacturing Services1998 β 2004
- Collaborative BioAllianceVP Business Development1998 β 2001
- LonzaAssociate Director, Business Development and Licensing1986 β 1998
- Celltech BiologicsAssociate Director, Business Development and Licensing1986 β 1995
- CelltechAssoc. Director, Business Development1986 β 1995
Skills & more
Non-clinical StudiesBiopharmaceuticalsTechnology Transfer43Biotechnology86Vaccines12Lifesciences31GMP57Validation20Pharmaceutical Industry31Drug Development53FDA21Commercialization15
+8 more
Process SimulationCross-functional Team LeadershipPurificationStart-upsClinical DevelopmentGLPDrug DeliveryPharmaceuticsFrom Susan's professional profile.
Frequently asked questions
- Who is Susan Dexter?
- Executive Officer at Sonnet BioTherapeutics Holdings
- Where does Susan Dexter work?
- Susan Dexter is Chief Technical Officer at Sonnet Biotherapeutics and Executive at Sonnet BioTherapeutics Holdings.
- Where did Susan Dexter go to school?
- Susan Dexter studied at American University (Bachelor of Applied Science (BASc), Immunology, Marketing Double Major); Middlesex Community College, MLT/ASCP (Associate of Science (A.S.), Medical Laboratory Technology); Harvard Business School (Certificateion, Negotiation for Lawyers, Finance for non-Financial Managers).
Same school
Also attended American University175
Vincent DialloInvestor at DaphniAmanda ThickpennyEvents Manager at NorthzoneCarleigh MorbaInvestor at Index VenturesMark KraynakInvestor at Aspect VenturesAndrew ForysiakOwner, AJF and Associates at Riphean InvestmentsJennifer HsiehDirector, Compliance at Deerfield Management Company
+ 169 more
Also attended Harvard Business School2,000
Aileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at FloodgateNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of PayhawkVictoria TreygerGeneral Partner at Felicis Ventures
+ 1,994 more
Shared employers
Also worked at Guidant BioTherapeutics1
Also worked at Sonnet BioTherapeutics, Inc.3
Also worked at Dow Chemical67
Mira InbarPartner at ArcTern VenturesFouad RakhaInvestment Associate at DisrupTech VenturesMichael PalmerGeneral Partner at Great Wave VenturesKevin ColasManaging Partner at Snatched VenturesTiffany HuangPrincipal at TransLink CapitalNataly AcostaSenior Manager, Investor Relations & Communications, LAC at Circulate Capital
+ 61 more
Also worked at Lonza22
Markus GemuendSenior Advisor at Adjuvant CapitalBrad MorieSenior Director, Biotechnologies at Research Corporation TechnologiesBenoit DubuisSwitzerland Board Member at MassChallenge MexicoPatrick StragierInvestment Manager at Meusinvest (Noshaq)Philippe StasInvestor at White FundAnΓsHead of Scoping, Pharma at Deep Science Ventures
+ 16 more


























